Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dare Bioscience

2.89
+0.00500.17%
Volume:9.70K
Turnover:28.13K
Market Cap:25.53M
PE:-6.05
High:2.92
Open:2.88
Low:2.88
Close:2.88
Loading ...

Dare Bioscience announces Notice of Award of grant from NIAID

TIPRANKS
·
06 Feb

Dare Bioscience: up to $2 Mln in Grant Funding May Provided by Niaid to Support Dare-Hpv Development

THOMSON REUTERS
·
06 Feb

Dare Bioscience Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Dec 2024

Dare Bioscience to Submit Plan for Phase 3 Study of Potential Female Sexual Disorder Treatment

MT Newswires Live
·
16 Dec 2024

Dare Bioscience announces Phase 3 plans for sildenafil cream in FSAD

TIPRANKS
·
16 Dec 2024

DarÉ Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (Fsad)

THOMSON REUTERS
·
16 Dec 2024

Dare Bioscience announces publication in Sexual Medicine on RESPOND study

TIPRANKS
·
10 Dec 2024

Dare Bioscience received payment of $2.5M under grant agreement

TIPRANKS
·
04 Dec 2024

DarÉ Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology Dare-Larc1

THOMSON REUTERS
·
04 Dec 2024

Press Release: Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Dow Jones
·
04 Dec 2024

Maxim Group Remains a Hold on Daré Bioscience (DARE)

TIPRANKS
·
16 Nov 2024

Dare Bioscience Files Prospectus for Resale of up to 2.8 Mln Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
16 Nov 2024

Q3 2024 Dare Bioscience Inc Earnings Call

Thomson Reuters StreetEvents
·
16 Nov 2024

Dare Bioscience Inc reports results for the quarter - Earnings Summary

Reuters
·
15 Nov 2024

Dare Bioscience Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Nov 2024